| Familial hyperlipoproteinemia, Uterine bleeding and mastodynia, Uterine fibroids,Impaired liver function, Fluid retention, Hypercalcemia and renal insufficiency, Addition of a progestin for seven or more days of a cycle of estrogen administration have reported a lowered incidence of endometrial hyperplasia, Gallbladder disease, Patients who have been treated for endometrial carcinoma,Endometriosis, Patients with pre-existing hypertension,Fibrocystic disease of the breast, Migraine headaches, Uterine leiomyoma, Women with previous thromboembolic disease. |